LFMT vs Placebo in New Biologic Start for Ulcerative Colitis
NCT05327790
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Ulcerative Colitis
Interventions
DRUG:
Lyophilized fecal microbiota (LFMT)
OTHER:
Placebo
Sponsor
University of Alberta